Suzuken Co., Ltd. (TYO:9987)
5,826.00
+31.00 (0.53%)
Sep 26, 2025, 3:30 PM JST
Suzuken Revenue
Suzuken had revenue of 592.87B JPY in the quarter ending June 30, 2025, with 1.83% growth. This brings the company's revenue in the last twelve months to 2.41T, up 0.65% year-over-year. In the fiscal year ending March 31, 2025, Suzuken had annual revenue of 2.40T with 0.56% growth.
Revenue (ttm)
2,410.63B
Revenue Growth
+0.65%
P/S Ratio
0.17
Revenue / Employee
186.54M
Employees
12,923
Market Cap
409.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 2,399.95B | 13.46B | 0.56% |
Mar 31, 2024 | 2,386.49B | 71.67B | 3.10% |
Mar 31, 2023 | 2,314.83B | 82.05B | 3.67% |
Mar 31, 2022 | 2,232.77B | 104.56B | 4.91% |
Mar 31, 2021 | 2,128.22B | -85.26B | -3.85% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |